November 2, 2023
SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in Thompson and Thompson Genetics and Genomics in Medicine, 9th edition, a textbook regularly used for medical students, genetic counseling students, students in laboratory medicine, and more advanced trainees pursuing American Board of Medical Genetics and [...]
Stellaromics Secures $25 Million in Series A Funding to Advance 3D Spatial Multi-omic Profiling
November 2, 2023
Life Sciences Pioneer Todd Dickinson, Ph.D., Appointed as CEO; Spatial Biology Innovator Ye Fu, PhD., Appointed as CTO Boston – Stellaromics, a leading provider of in situ spatial multi-omics technology, today announced that the company has raised $25 million in a Series A financing round. The Series A financing round included Plaisance Capital Management and [...]
Complete Genomics and Basepair™ Announce Technology Integration Partnership
November 2, 2023
SAN JOSE & NEW YORK – Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics’ DNBSEQ™ sequencing platforms. The partnership gives Complete Genomics’ customers seamless access to Basepair’s bioinformatics platform deployed on Amazon Web Services (AWS) and use its easy-to-use [...]
November 2, 2023
Centralized hub for advanced testing of nucleic acids to simplify mRNA drug substance testing, accelerating critical therapeutic development SAN DIEGO –TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its Analytical Sciences Center of Excellence (ASCE) hub. Expanding its comprehensive suite of analytical testing capabilities, this [...]
November 2, 2023
WATERTOWN, Mass. — Fluent BioSciences, a cutting-edge life science company transforming single cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions, is excited to announce a partnership with Singular Genomics, a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians. Together, they unveil the compatibility of PIPseq™ [...]
Genomenon Takes a Leap in the Race to Curate the Genome
November 2, 2023
Company Releases Mastermind 3.0 with the Clinical Exome Fully Curated at the Gene Level Genomenon Inc., a leading genomic intelligence company, today announced the first milestone in its journey to curate the human genome with the release of Mastermind 3.0, now including the clinical exome fully curated at the gene level. With this latest launch of [...]
Ajinomoto Genexine changes its name to Ajinomoto CELLiST Korea
November 1, 2023
Ajinomoto Genexine announced that it will change its name to ‘Ajinomoto CELLiST Korea’. Last July, Ajinomoto acquired the entire 25% stake held by Genexine, securing a 100% stake in Ajinomoto Genexine. Ajinomoto, a leading supplier in the global market of amino acids for pharmaceuticals and food, is accelerating its business as a medium for biopharmaceuticals [...]
Genomic Vision Expands Its Replication Combing Assay Service Offering
November 1, 2023
Genomic Vision expands its Replication Combing Assay (RCA) services to meet specific pharmaceutical needs, resulting in invaluable insights. Genomic Vision now can provide new replication parameters that allow a better understanding of the mechanism of action of drugs and help define the role of some pathways in cancer progression. Total sales linked to the RCA [...]
Complete Genomics presents at ASHG 2023
November 1, 2023
Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S. WASHINGTON – Complete Genomics, a pioneering genomic sequencing company, announced today at the American Society of Human Genetics (ASHG) Annual Meeting, Nov. 1-5, in Washington details on the commercial [...]
November 1, 2023
Partnerships Maximize Value of HiFi Data and Complete the Full End-to-End Workflow for PacBio Customers. MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the addition of two tertiary analysis partners to PacBio Compatible. Geneyx and Golden Helix will enable PacBio customers to leverage PacBio HiFi data for disease research with the Revio, [...]

